Ionic Residues of Human Serum Transferrin Affect Binding to the Transferrin Receptor and Iron Release

详细信息    查看全文

• 作者：Ashley N. Steere ; Brendan F. Miller ; Samantha E. Roberts ; Shaina L. Byrne ; N. Dennis Chasteen ; Valerie C. Smith ; Ross T. A. MacGillivray ; Anne B. Mason
• 刊名：Biochemistry
• 出版年：2012
• 出版时间：January 17, 2012
• 年：2012
• 卷：51
• 期：2
• 页码：686-694
• 全文大小：349K
• 年卷期：v.51,no.2(January 17, 2012)
• ISSN：1520-4995

文摘

Efficient delivery of iron is critically dependent on the binding of diferric human serum transferrin (hTF) to its specific receptor (TFR) on the surface of actively dividing cells. Internalization of the complex into an endosome precedes iron removal. The return of hTF to the blood to continue the iron delivery cycle relies on the maintenance of the interaction between apohTF and the TFR after exposure to endosomal pH (鈮?.0). Identification of the specific residues accounting for the pH-sensitive nanomolar affinity with which hTF binds to TFR throughout the cycle is important to fully understand the iron delivery process. Alanine substitution of 11 charged hTF residues identified by available structures and modeling studies allowed evaluation of the role of each in (1) binding of hTF to the TFR and (2) TFR-mediated iron release. Six hTF mutants (R50A, R352A, D356A, E357A, E367A, and K511A) competed poorly with biotinylated diferric hTF for binding to TFR. In particular, we show that Asp356 in the C-lobe of hTF is essential to the formation of a stable hTF鈥揟FR complex: mutation of Asp356 in the monoferric C-lobe hTF background prevented the formation of the stoichiometric 2:2 (hTF:TFR monomer) complex. Moreover, mutation of three residues (Asp356, Glu367, and Lys511), whether in the diferric or monoferric C-lobe hTF, significantly affected iron release when in complex with the TFR. Thus, mutagenesis of charged hTF residues has allowed identification of a number of residues that are critical to formation of and release of iron from the hTF鈥揟FR complex.